Certara Mid-Year Update: Latest insights on AI, drug development and more.?
Welcome to the Certara Inner Circle! The leading monthly newsletter to help bring greater certainty to drug development from molecule to market.

Certara Mid-Year Update: Latest insights on AI, drug development and more.?

The Certara team has compiled the latest drug development trends and insights in the June Inner Circle newsletter. As we reach mid-2024, we want to keep you informed about the latest trends and how Certara's solutions help clients reduce risk and bring certainty to all stages of drug development.

In this issue, you'll find articles on trending topics in the life sciences industry, such as using generative AI for medical writing, designing smarter clinical trials with virtual trials, and best practices for developing radiopharmaceuticals.

Together with our client community, Certara is at the forefront of solving critical drug development challenges. Reach out anytime for assistance with your drug program's regulatory, scientific, and commercial needs.?Contact us?today!



WEBINAR

Introducing CoAuthor?: The GenAI-Enabled Solution for Regulatory Writers

Join our webinar to see how CoAuthor from Certara revolutionizes regulatory writing with advanced features and specialized generative AI in Microsoft Word, streamlining document creation. Experience the benefits firsthand from Certara's expert teams.

Date:?June 25, 2024

Time:?10am - 11am ET

REGISTER NOW


BLOG

The Future is Now: Virtual Clinical Trials Transforming Drug Development

Did you know that virtual clinical trials can save time and yield results faster compared to traditional methods and inform better clinical designs? That's why this approach is increasingly embraced by regulatory agencies. Read this blog to learn how the “parallel virtual universe” is reshaping clinical trials.

READ THE BLOG


WEBINAR

Clinical Pharmacology & Model-Informed Drug Development Insights?for Targeted?Radiation Therapies

This webinar will illustrate how clinical pharmacology considerations and model-informed drug development (MIDD) concepts can help streamline therapeutic index-focused discovery and drug development for targeted radiation therapies.

Date:?June 24, 2024

Time:?11am - 12pm ET

REGISTER NOW


Our global pharmacometrics leaders will showcase scientific excellence at PAGE 2024 with 35+ innovative posters, workshops, and an oral presentation on Real-World Data analysis. Join us at the annual European Futbol Pharmacometrics Collective and visit booths 23 and 24 to discuss partnership opportunities.

LEARN MORE


ARTICLE

Deregulating Psychedelics To Propel Clinical Research

Read this article in?Technology Networks?to learn why deregulation of psychedelics scheduling will accelerate the gathering of clinical research data on their therapeutic potential.

READ MORE


CASE STUDY

Streamlining Biotech Data Compliance and Management with Certara's Phoenix Hosted

Learn how Phoenix Hosted provided our biotech client with a significant step forward by simplifying data review, QA, and audits.

READ THE CASE STUDY


VIDEO

How Will Generative AI Take Your Regulatory and Medical Writing Program to the Next Level?

How will Generative AI revolutionize regulatory and medical writing? Find out in this video. Learn how lean authoring techniques and technologies can create efficiencies and increase productivity in the regulatory writing process.

WATCH THE VIDEO


Register now to attend live scientific webinars:

Where to find Certara this Summer:


Enjoying the?Inner?Circle? Don't forget to?subscribe?at the top or bottom.?Want to share? Click share below.

Have questions about our services and software? Contact us.


About Certara

Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries.?

Corporate Headquarters: 4 Radnor Corporate Center, Suite 350, Radnor, PA 19087 USA

Kristopher Sarajian

Communicator. Sales partner. Brand builder.

4 个月

Love this format btw!

回复
Muhammad L.

Consultant| Professor of Pharmacology & Neuroscience| Researcher (Neuro/AI) | Editor | Electrophysiology| CRISPR-Cas9| Natural Products| Trainer| Writer|?Innovator|?Motivator| Entrepreneur| Pharmapreneur| Health-Tech

4 个月

https://www.dhirubhai.net/posts/liaquat_call-for-submission-in-an-special-issue-activity-7214827754582618112-O5V1?utm_source=share&utm_medium=member_android *Call for Submission in an special issue* Titled *Advancements in Robotic and AI-based Drug Discovery and Delivery for Neurological Disorders* In *Journal: Current Drug Delivery* Having *Impact Factor: 2.4* *Indexed in: Scopus, SCI Expanded, MEDLINE/PubMed* *Guest editor(s):* Dr. Indranath Chatterjee (UK) Dr. Nasrollah Moradikor (Georgia), Prof. Dr. Muhammad Liaquat Raza (KSA) *Deadline: 06 Nov 2024*

回复
Anshuman Mishra

Digital Transformation using Transformative AI & Analytics | Healthcare & Life Sciences

5 个月

Exciting!

回复

要查看或添加评论,请登录

Certara的更多文章

社区洞察

其他会员也浏览了